When Tulsi Gabbard sounded the alarm about American-funded biological laboratories inside Ukraine shortly after Russia launched its 2022 invasion, the political establishment came down hard.
Critics labeled her a mouthpiece for the Kremlin. Now, as Director of National Intelligence, Gabbard has released a cache of declassified government records — and the contents are difficult to dismiss.
The documents confirm that the United States has financially supported more than 120 biological laboratories operating across more than 30 countries.
Gabbard has stated plainly that these records prove what she and others were condemned for saying out loud years ago.
At the center of the disclosure are ODNI briefing slides that map out the reach of American involvement in Ukraine’s laboratory network.
According to those records, more than 40 Ukrainian laboratories operated with U.S. financial backing.
What those labs contained raises serious questions.
The declassified files document collections of dangerous bacteria and viruses stored inside the facilities — some of them remnants of the Soviet biological program, preserved and maintained decades after the Cold War ended.
American investment in those facilities went beyond writing checks. Ukrainian scientists received U.S.-funded instruction in working directly with hazardous pathogens.
A separate documented initiative trained personnel in protocols specific to especially dangerous diseases.
The pathogen inventory named in the records reads like a worst-case scenario list: anthrax, tuberculosis, plague, Ebola virus, Marburg virus, MERS, and SARS. Each of those agents carries the potential for catastrophic human consequences if mishandled or deliberately released.
Physical infrastructure also received American dollars.
The records trace U.S.-funded construction and laboratory upgrades at sites in Kherson, Odesa, and western Ukraine. Engineering firm Black & Veatch surfaces repeatedly in the documents as a leading contractor on those projects.
The price tags attached to individual laboratory projects ranged from roughly $1.7 million to $3.5 million per site — all drawn from U.S. taxpayer funds. The cumulative investment across the entire Ukrainian network represents a substantial and largely undisclosed financial commitment.
A declassified assessment zeroes in on a veterinary research facility in Kharkiv that drew direct Pentagon funding through the Defense Department’s Biological Threat Reduction Program.
That laboratory was holding hundreds of pathogen samples, including Brucella bacteria, the agent behind a disease called brucellosis.
The same assessment flagged the Kharkiv site as a potential vulnerability.
With active combat operations unfolding across Ukraine, officials warned the facility could be targeted by Russian information operations or physically compromised through damage or capture.
One ODNI slide takes a wider view, charting what it explicitly calls a “web of connections” threading Ukrainian laboratories together with American federal agencies, academic institutions, private research organizations, and outside contractors.
That web, per the document, funded studies on bird flu and other highly contagious viruses inside high-security lab environments.
Gabbard has framed the entire disclosure as a transparency issue — arguing the American public was deliberately kept in the dark about the scale and nature of U.S.-sponsored biological research programs operating on foreign soil.
Those who defended the laboratories from the beginning have not changed their position.
Critics of the declassification continue to argue the facilities served legitimate purposes — securing unstable pathogen stockpiles and preventing biological threats from falling into dangerous hands rather than advancing any weapons agenda.
The argument over intent, however, may prove secondary to the argument over disclosure.
Whether the labs were defensive or not, the records confirm that the American government funded an extensive overseas biological research network that was never fully explained to the public.
That gap between what was happening and what citizens were told is now documented — and it arrives at a moment when questions about government credibility on scientific matters remain far from settled.
